Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

The eSMART study protocol: a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system (ASyMS) remote technology for patients with cancer.

Maguire R, Fox PA, McCann L, Miaskowski C, Kotronoulas G, Miller M, Furlong E, Ream E, Armes J, Patiraki E, Gaiger A, Berg GV, Flowerday A, Donnan P, McCrone P, Apostolidis K, Harris J, Katsaragakis S, Buick AR, Kearney N.

BMJ Open. 2017 Jun 6;7(5):e015016. doi: 10.1136/bmjopen-2016-015016.

2.

Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.

Mayerhoefer ME, Karanikas G, Kletter K, Prosch H, Kiesewetter B, Skrabs C, Porpaczy E, Weber M, Pinker-Domenig K, Berzaczy D, Hoffmann M, Sillaber C, Jaeger U, Müllauer L, Simonitsch-Klupp I, Dolak W, Gaiger A, Ubl P, Lukas J, Raderer M.

Clin Cancer Res. 2014 Jun 1;20(11):2984-93. doi: 10.1158/1078-0432.CCR-13-3355. Epub 2014 Apr 2.

3.

The caregivers' perspective on the end-of-life phase of glioblastoma patients.

Flechl B, Ackerl M, Sax C, Oberndorfer S, Calabek B, Sizoo E, Reijneveld J, Crevenna R, Keilani M, Gaiger A, Dieckmann K, Preusser M, Taphoorn MJ, Marosi C.

J Neurooncol. 2013 May;112(3):403-11. doi: 10.1007/s11060-013-1069-7. Epub 2013 Feb 15.

PMID:
23412776
4.

Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia.

Gruber M, Bellemare J, Hoermann G, Gleiss A, Porpaczy E, Bilban M, Le T, Zehetmayer S, Mannhalter C, Gaiger A, Shehata M, Fleiss K, Skrabs C, Lévesque É, Vanura K, Guillemette C, Jaeger U.

Blood. 2013 Feb 14;121(7):1175-83. doi: 10.1182/blood-2012-08-447359. Epub 2012 Nov 20.

5.

Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors.

Flechl B, Ackerl M, Sax C, Dieckmann K, Crevenna R, Gaiger A, Widhalm G, Preusser M, Marosi C.

J Neurooncol. 2012 Sep;109(2):331-9. doi: 10.1007/s11060-012-0897-1. Epub 2012 May 29.

PMID:
22644537
6.

Overexpression of G protein-coupled receptor 5D in the bone marrow is associated with poor prognosis in patients with multiple myeloma.

Atamaniuk J, Gleiss A, Porpaczy E, Kainz B, Grunt TW, Raderer M, Hilgarth B, Drach J, Ludwig H, Gisslinger H, Jaeger U, Gaiger A.

Eur J Clin Invest. 2012 Sep;42(9):953-60. doi: 10.1111/j.1365-2362.2012.02679.x. Epub 2012 May 16.

PMID:
22591013
7.

Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response.

Jäger U, Fridrik M, Zeitlinger M, Heintel D, Hopfinger G, Burgstaller S, Mannhalter C, Oberaigner W, Porpaczy E, Skrabs C, Einberger C, Drach J, Raderer M, Gaiger A, Putman M, Greil R; Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT) Investigators.

Haematologica. 2012 Sep;97(9):1431-8. Epub 2012 Apr 17.

8.

Prolonged progression-free survival in patients with chronic lymphocytic leukemia receiving granulocyte colony-stimulating factor during treatment with fludarabine, cyclophosphamide, and rituximab.

Gruber M, Fleiss K, Porpaczy E, Skrabs C, Hauswirth AW, Gaiger A, Vanura K, Heintel D, Shehata M, Einberger C, Thalhammer R, Fonatsch C, Jäger U.

Ann Hematol. 2011 Oct;90(10):1131-6. doi: 10.1007/s00277-011-1260-x. Epub 2011 May 27.

PMID:
21617923
9.

Prevalence and clinical impact of autoimmune diseases and chronic infections in malignant lymphomas at diagnosis.

Vanura K, Späth F, Gleiss A, Le T, Porpaczy E, Skrabs C, Hauswirth A, Fleiss K, Wessely F, Gaiger A, Müllauer L, Jäger U.

Ann Hematol. 2011 Aug;90(8):947-54. doi: 10.1007/s00277-011-1178-3. Epub 2011 Feb 17.

PMID:
21327940
10.

Sequential gene expression profiling during treatment for identification of predictive markers and novel therapeutic targets in chronic lymphocytic leukemia.

Shehata M, Demirtas D, Schnabl S, Hilgarth M, Hubmann R, Fonatsch C, Schwarzinger I, Hopfinger G, Eigenberger K, Heintel D, Porpaczy E, Vanura K, Hauswirth A, Schwarzmeier JD, Gaiger A, Stilgenbauer S, Hallek M, Bilban M, Jäger U.

Leukemia. 2010 Dec;24(12):2122-7. doi: 10.1038/leu.2010.220. Epub 2010 Oct 22. No abstract available.

PMID:
20966934
11.

Reconstitution of PTEN activity by CK2 inhibitors and interference with the PI3-K/Akt cascade counteract the antiapoptotic effect of human stromal cells in chronic lymphocytic leukemia.

Shehata M, Schnabl S, Demirtas D, Hilgarth M, Hubmann R, Ponath E, Badrnya S, Lehner C, Hoelbl A, Duechler M, Gaiger A, Zielinski C, Schwarzmeier JD, Jaeger U.

Blood. 2010 Oct 7;116(14):2513-21. doi: 10.1182/blood-2009-10-248054. Epub 2010 Jun 24.

12.

Nonpegylated liposomal doxorubicin is highly active in patients with B and T/NK cell lymphomas with cardiac comorbidity or higher age.

Heintel D, Skrabs C, Hauswirth A, Eigenberger K, Einberger C, Raderer M, Sperr WR, Knöbl P, Müllauer L, Uffmann M, Dieckmann K, Gaiger A, Jäger U.

Ann Hematol. 2010 Feb;89(2):163-9. doi: 10.1007/s00277-009-0796-5. Epub 2009 Jul 28.

PMID:
19636553
13.

Autoimmune conditions and chronic infections in chronic lymphocytic leukemia patients at diagnosis are associated with unmutated IgVH genes.

Vanura K, Le T, Esterbauer H, Späth F, Porpaczy E, Shehata M, Eigenberger K, Hauswirth A, Skrabs C, Krömer E, Schwarzinger I, Streubel B, Steininger C, Fonatsch C, Stilgenbauer S, Wagner O, Gaiger A, Jäger U.

Haematologica. 2008 Dec;93(12):1912-6. doi: 10.3324/haematol.12955. Epub 2008 Oct 6.

14.

Grey-scale and colour Doppler sonography in the evaluation of children with suspected bowel inflammation: correlation with colonoscopy and histological findings.

Epifanio M, Baldisserotto M, Spolidoro JV, Gaiger A.

Clin Radiol. 2008 Sep;63(9):968-78. doi: 10.1016/j.crad.2008.02.009. Epub 2008 Apr 22.

PMID:
18718226
15.

Characterization of a lymphocyte subset displaying a unique regulatory activity in human decidua.

Amsalem H, Gaiger A, Mizrahi S, Yagel S, Rachmilewitz J.

Int Immunol. 2008 Sep;20(9):1147-54. doi: 10.1093/intimm/dxn072. Epub 2008 Jul 14.

PMID:
18628237
16.

Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide.

Stary G, Kohrgruber N, Herneth AM, Gaiger A, Stingl G, Rieger A.

AIDS. 2008 Jun 19;22(10):1232-4. doi: 10.1097/QAD.0b013e3282fa75ce. No abstract available.

PMID:
18525273
17.

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.

Gryshchenko I, Hofbauer S, Stoecher M, Daniel PT, Steurer M, Gaiger A, Eigenberger K, Greil R, Tinhofer I.

J Clin Oncol. 2008 May 10;26(14):2252-7. doi: 10.1200/JCO.2007.11.5212.

PMID:
18467716
18.

Prognostic value of T-cell receptor gamma rearrangement in peripheral blood or bone marrow of patients with peripheral T-cell lymphomas.

Schützinger C, Esterbauer H, Hron G, Skrabs C, Uffmann M, Raderer M, Hauswirth A, Mannhalter C, Dieckmann K, Wagner O, Formanek M, Stift A, Friedl J, Gaiger A, Chott A, Jäger U.

Leuk Lymphoma. 2008 Feb;49(2):237-46. doi: 10.1080/10428190701784409.

PMID:
18231909
19.

Expression of MUM1/IRF4 mRNA as a prognostic marker in patients with multiple myeloma.

Heintel D, Zojer N, Schreder M, Strasser-Weippl K, Kainz B, Vesely M, Gisslinger H, Drach J, Gaiger A, Jäger U, Ludwig H.

Leukemia. 2008 Feb;22(2):441-5. Epub 2007 Aug 9. No abstract available.

PMID:
17690696
20.

Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high-risk B-cell chronic lymphocytic leukemia.

Kainz B, Shehata M, Bilban M, Kienle D, Heintel D, Krömer-Holzinger E, Le T, Kröber A, Heller G, Schwarzinger I, Demirtas D, Chott A, Döhner H, Zöchbauer-Müller S, Fonatsch C, Zielinski C, Stilgenbauer S, Gaiger A, Wagner O, Jäger U.

Int J Cancer. 2007 Nov 1;121(9):1984-93.

21.

Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas.

Hauswirth AW, Skrabs C, Schützinger C, Gaiger A, Lechner K, Jäger U.

Leuk Lymphoma. 2007 Jun;48(6):1139-49. Review.

PMID:
17577777
22.

Clinical study on the effect of infrared radiation of a tiled stove on patients with hand osteoarthritis.

Stange-Rezende L, Stamm TA, Schiffert T, Sahinbegovic E, Gaiger A, Smolen J, Machold KP.

Scand J Rheumatol. 2006 Nov-Dec;35(6):476-80.

PMID:
17343258
23.

Upregulation of retinoic acid receptor-beta by the epidermal growth factor-receptor inhibitor PD153035 is not mediated by blockade of ErbB pathways.

Grunt TW, Tomek K, Wagner R, Puckmair K, Kainz B, Rünzler D, Gaiger A, Köhler G, Zielinski CC.

J Cell Physiol. 2007 Jun;211(3):803-15.

PMID:
17286282
24.

Influence of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseases.

Wöhrer S, Troch M, Zwerina J, Schett G, Skrabs C, Gaiger A, Jaeger U, Zielinski CC, Raderer M.

Ann Oncol. 2007 Apr;18(4):647-51. Epub 2007 Jan 11.

PMID:
17218490
25.

Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience.

Raderer M, Wöhrer S, Streubel B, Troch M, Turetschek K, Jäger U, Skrabs C, Gaiger A, Drach J, Puespoek A, Formanek M, Hoffmann M, Hauff W, Chott A.

J Clin Oncol. 2006 Jul 1;24(19):3136-41. Epub 2006 Jun 12.

PMID:
16769982
26.

Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression.

Bilban M, Heintel D, Scharl T, Woelfel T, Auer MM, Porpaczy E, Kainz B, Kröber A, Carey VJ, Shehata M, Zielinski C, Pickl W, Stilgenbauer S, Gaiger A, Wagner O, Jäger U; German CLL Study Group.

Leukemia. 2006 Jun;20(6):1080-8.

PMID:
16617321
27.

Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma.

Raderer M, Wöhrer S, Bartsch R, Prager G, Drach J, Hejna M, Gaiger A, Turetschek K, Jaeger U, Streubel B, Zielinski CC.

J Clin Oncol. 2005 Nov 20;23(33):8442-6.

PMID:
16293875
28.

Remission of pure red cell aplasia in T-cell receptor gammadelta-large granular lymphocyte leukemia after therapy with low-dose alemtuzumab.

Schützinger C, Gaiger A, Thalhammer R, Vesely M, Fritsche-Polanz R, Schwarzinger I, Ohler L, Simonitsch-Klupp I, Reinhard F, Jäger U.

Leukemia. 2005 Nov;19(11):2005-8. No abstract available.

PMID:
16193089
29.

Beckwith-Wiedemann syndrome and bilateral adrenal pheochromocytoma: sonography and MRI findings.

Baldisserotto M, Peletti AB, Angelo de Araújo M, Pertence AP, Dora MD, Maciel EO, Gaiger AM.

Pediatr Radiol. 2005 Nov;35(11):1132-4. Epub 2005 Jun 28.

PMID:
15983774
30.

Limited value of FLT3 mRNA expression in the bone marrow for prognosis and monitoring of patients with acute myeloid leukemia.

Kainz B, Fonatsch C, Schwarzinger I, Sperr WR, Jäger U, Gaiger A.

Haematologica. 2005 May;90(5):695-6.

31.

Wilms' tumour gene 1 (WT1) in human neoplasia.

Keilholz U, Menssen HD, Gaiger A, Menke A, Oji Y, Oka Y, Scheibenbogen C, Stauss H, Thiel E, Sugiyama H.

Leukemia. 2005 Aug;19(8):1318-23.

PMID:
15920488
32.

High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia.

Heintel D, Kienle D, Shehata M, Kröber A, Kroemer E, Schwarzinger I, Mitteregger D, Le T, Gleiss A, Mannhalter C, Chott A, Schwarzmeier J, Fonatsch C, Gaiger A, Döhner H, Stilgenbauer S, Jäger U; CLL Study Group.

Leukemia. 2005 Jul;19(7):1216-23.

PMID:
15858619
33.

An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells.

Grunt TW, Puckmair K, Tomek K, Kainz B, Gaiger A.

Biochem Biophys Res Commun. 2005 Apr 22;329(4):1253-9.

PMID:
15766561
34.

Novel molecular diagnostic and therapeutic targets in chronic lymphocytic leukaemia.

Gaiger A, Heintel D, Jäger U.

Eur J Clin Invest. 2004 Aug;34 Suppl 2:25-30. Review.

PMID:
15291803
35.

High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia.

Heintel D, Kroemer E, Kienle D, Schwarzinger I, Gleiss A, Schwarzmeier J, Marculescu R, Le T, Mannhalter C, Gaiger A, Stilgenbauer S, Döhner H, Fonatsch C, Jäger U; German CLL Study Group.

Leukemia. 2004 Apr;18(4):756-62.

PMID:
14961036
37.
38.

Rituximab and rapamycin for posttransplant lymphoproliferative disease treatment: report of three cases.

Garcia VD, Bonamigo-Filho JS, Neumann J, Fogliatto L, Gaiger AM, Garcia CD, Barros V, Keitel E, Bittar AE, Santos AF, Roithmann S.

Transplant Proc. 2002 Nov;34(7):2993-5. No abstract available.

PMID:
12431680
39.

WT1-specific serum antibodies in patients with leukemia.

Gaiger A, Carter L, Greinix H, Carter D, McNeill PD, Houghton RL, Cornellison CD, Vedvick TS, Skeiky YA, Cheever MA.

Clin Cancer Res. 2001 Mar;7(3 Suppl):761s-765s.

PMID:
11300470
40.

Immunity to WT1 in the animal model and in patients with acute myeloid leukemia.

Gaiger A, Reese V, Disis ML, Cheever MA.

Blood. 2000 Aug 15;96(4):1480-9.

41.

Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol.

Gaiger A, Linnerth B, Mann G, Schmid D, Heinze G, Tisljar K, Haas OA, Gadner H, Lion T.

Eur J Haematol. 1999 Aug;63(2):86-93.

PMID:
10480287
42.

Immunophenotypic characterization of human bone marrow endosteal cells.

Sillaber C, Walchshofer S, Mosberger I, Gaiger A, Simonitsch I, Chott A, Lechner K, Valent P.

Tissue Antigens. 1999 Jun;53(6):559-68.

PMID:
10395106
43.

Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia.

Boultwood J, Fidler C, Shepherd P, Watkins F, Snowball J, Haynes S, Kusec R, Gaiger A, Littlewood TJ, Peniket AJ, Wainscoat JS.

Am J Hematol. 1999 May;61(1):5-9.

44.

Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia.

Gaiger A, Schmid D, Heinze G, Linnerth B, Greinix H, Kalhs P, Tisljar K, Priglinger S, Laczika K, Mitterbauer M, Novak M, Mitterbauer G, Mannhalter C, Haas OA, Lechner K, Jäger U.

Leukemia. 1998 Dec;12(12):1886-94.

PMID:
9844919
45.

Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia.

Schmid D, Heinze G, Linnerth B, Tisljar K, Kusec R, Geissler K, Sillaber C, Laczika K, Mitterbauer M, Zöchbauer S, Mannhalter C, Haas OA, Lechner K, Jäger U, Gaiger A.

Leukemia. 1997 May;11(5):639-43.

PMID:
9180285
46.

Amplification of mitochondrial DNA in acute myeloid leukaemia.

Boultwood J, Fidler C, Mills KI, Frodsham PM, Kusec R, Gaiger A, Gale RE, Linch DC, Littlewood TJ, Moss PA, Wainscoat JS.

Br J Haematol. 1996 Nov;95(2):426-31.

PMID:
8904904
47.

Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression.

Gaiger A, Henn T, Hörth E, Geissler K, Mitterbauer G, Maier-Dobersberger T, Greinix H, Mannhalter C, Haas OA, Lechner K, Lion T.

Blood. 1995 Sep 15;86(6):2371-8.

48.

Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon.

Lion T, Gaiger A, Henn T, Hörth E, Haas OA, Geissler K, Gadner H.

Leukemia. 1995 Aug;9(8):1353-60.

PMID:
7643624
49.

PCR-monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR-ABL-positive acute lymphoblastic leukaemia.

Mitterbauer G, Födinger M, Scherrer R, Knöbl P, Jäger U, Laczika K, Schwarzinger I, Gaiger A, Geissler K, Greinix H, et al.

Br J Haematol. 1995 Apr;89(4):937-41. Erratum in: Br J Haematol 1995 Jun;90(2):492.

PMID:
7772540
50.

Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.

Watzinger F, Gaiger A, Karlic H, Becher R, Pillwein K, Lion T.

Cancer Res. 1994 Jul 15;54(14):3934-8.

Supplemental Content

Loading ...
Support Center